A group of researchers has recently discovered that an immune mechanism responsible in clearing bacterial infections may also be involved in causing Parkinson’s disease. The study has identified the role of protein LRRK2 in tuberculosis, results have shown that it behaves similarly in Parkinson disease. This finding could pave the way for advance treatments for both diseases. A mutation in LRRK2 gene is common in Parkinson’s patients and LRRK2 blockers are showing promise against it. However, the exact mechanism of how this mutation causes the disease is still unknown. Currently, there are drugs based on LRRK2 for treating Parkinson’s that could be repurposed for Tuberculosis. Drug resistant TB is on the rise and Bacille-Calmette-Guérin (BCG) is the only WHO-approved TB vaccine that shows variable efficacy in adults, due Researchers are continuously searching for more effective treatment options.
DelveInsight Blog

How is Nanomedicine Transforming the Dynam...
Jun 22, 2022
Over the span of the last decade, new and revolutionary technology has been introduced into our daily lives - nanotec...

Commercial Roadmap for the Launch: What ca...
May 02, 2022
The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of the type of biopharmaceutical...

Mapping the Biggest Pharmaceutical Compani...
Feb 11, 2022
Today, the most important factor affecting the world’s economy is the Global Pharmaceutical Industry. This industry i...
Sign Up and Stay Informed
Penetrative insights and rich analysis of Pharma, Biotech and MedTech space.
Editor's Pick
Can denovoSkin Be A Lifesaver for Burn Victims?
Burn is a global public health problem, causing more than 180,000 deaths per year acros...
NexoBrid and its Awaiting US Approval
A Burn takes place when the skin comes into contact with a heat source. Burns can occur...
New Clinical Developments in the Pulmonary Arterial Hypertension Treatment Do...
Pulmonary arterial hypertension is a progressive disease of the lung vascular system, p...
Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase...
The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...
Emerging Market for Organ on a Chip
The organ on a chip is a microfluidic culture device that recapitulates the complicated...
RECENT ARTICLES